Coronavirus: Antiviral drug Remdesivir performs well in trials
A trial of the antiviral drug remdesivir has produced ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead announced the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 patients, who were sick enough … Read more
